$ELTP 5-bagger corrected $0.33 called 9/21/13 $0
Post# of 2146
Posted On: 04/17/2016 8:35:20 PM
$ELTP 5-bagger corrected $0.33
called 9/21/13 $0.13
Website
Shares Outstanding: 695.17M
Float: 586.92M
% Held by Insiders: 16.55%
% Held by Institutions: 0.20%
Shares Short (as of Apr 30, 2009): 757.07K
Short Ratio (as of Apr 30, 2009): 0.87
Short % of Float (as of Apr 30, 2009): N/A
Shares Short (prior month): 1.61M
Headlines
Company Profile - Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and licensing of proprietary controlled-release drug delivery systems and products. It develops orally administered controlled-release products that comprise drugs that cover various therapeutic areas, including pain, allergy, and infection. The company owns, licenses, or contract manufactures Phentermine HCl tablets, Lodrane D Immediate Release capsules, Methadone HCl tablets, Hydromorphone HCl tablets, Phendimetrazine tartrate tablets, Naltrexone HCl tablets, Isradipine capsules, and Hydroxyzine tablets. It is also developing abuse resistant opioid products. In addition, the company engages in the contract research and development activities on behalf of other pharmaceutical companies. Elite Pharmaceuticals, Inc. was founded in 1984 and is headquartered in Northvale, New Jersey.
called 9/21/13 $0.13
Website
Shares Outstanding: 695.17M
Float: 586.92M
% Held by Insiders: 16.55%
% Held by Institutions: 0.20%
Shares Short (as of Apr 30, 2009): 757.07K
Short Ratio (as of Apr 30, 2009): 0.87
Short % of Float (as of Apr 30, 2009): N/A
Shares Short (prior month): 1.61M
Headlines
Company Profile - Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and licensing of proprietary controlled-release drug delivery systems and products. It develops orally administered controlled-release products that comprise drugs that cover various therapeutic areas, including pain, allergy, and infection. The company owns, licenses, or contract manufactures Phentermine HCl tablets, Lodrane D Immediate Release capsules, Methadone HCl tablets, Hydromorphone HCl tablets, Phendimetrazine tartrate tablets, Naltrexone HCl tablets, Isradipine capsules, and Hydroxyzine tablets. It is also developing abuse resistant opioid products. In addition, the company engages in the contract research and development activities on behalf of other pharmaceutical companies. Elite Pharmaceuticals, Inc. was founded in 1984 and is headquartered in Northvale, New Jersey.
(0)
(0)Elite Pharmaceuticals Inc (ELTP) Stock Research Links
Scroll down for more posts ▼